Vascular Mechanobiology and Oxidative Stress: Dr. Alevriadou’s expertise lies in vascular endothelial mechanotransduction (signal transduction due to fluid shear stress), free radical (reactive oxygen species) and calcium signaling, and mitochondrial biology. In general, understanding the role of the mechanochemical environment on cellular/molecular mechanisms of cardiovascular diseases (atherosclerosis, ischemia/reperfusion injury, inflammation, thrombosis, diabetes).

• August 2018–June 2022
  Control of Endothelial Mechanotransduction by the Mitochondrial Ca2+ Uniporter: Implications for Atherosclerosis. Alevriadou BR (PI), Madesh M (co-PI). Agency: NIH/NHLBI. Type: R01 HL142673. Total cost: $1.82 million
  Role: Principal Investigator
  
• January 2016–June 2018
  Redox Regulation of Autophagy in Postischemic Vascular Endothelial Cells. Alevriadou BR (PI), Zweier JL (co-I). Agency: AHA. Type: Grant-In-Aid. Total cost: $154,000
  Role: Principal Investigator
  
• June 2011–May 2013
  Emerging Functions of Mitochondrial Fission in Postischemic Endothelial Cells. Alevriadou BR (PI), Matzavinos A (co-I). Agency: NIH/NHLBI. Type: R21 HL106392. Total cost: $423,000
  Role: Principal Investigator
  
• January 2008–December 2009
  Mechanoregulation of Endothelial Mitochondrial Function. Alevriadou BR (PI), Chen Y-R (co-I), Szeto HH (co-I). Agency: NIH/NHLBI. Type: R21 HL091417. Total cost: $410,000
  Role: Principal Investigator
  
• December 2001–February 2006
  Reperfusion-Induced Endothelial Cell Dysfunction. Alevriadou BR (PI), Irani K (co-I). Agency: NIH/NHLBI. Type: R01 HL067027. Total cost: $1.25 million
  Role: Principal Investigator